Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | LTA4H | P09960 | 1/20 | 0.59 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5205368 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1552926 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| Methane SCHEMBL7287824 | 0.98 | ALDH1A1 (0.97) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| Hydrochloric Acid SCHEMBL5343928 | 0.98 | ALDH1A1 (0.97) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL2538632 | 0.95 | ALDH1A1 (0.90) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL24023495 | 0.91 | ALDH1A1 (0.82) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL5745229 | 0.90 | ALDH1A1 (0.81) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL608225 | 0.89 | ALDH1A1 (0.81) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL741364 | 0.89 | ALDH1A1 (0.81) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL72716 | 0.89 | ALDH1A1 (0.81) | ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113461598-B | Process for producing piperidinol compound | 山东华素制药有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-113640408-B | Method for analyzing piperidinol compound | 山东华素制药有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-113264868-B | Improved synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-111848495-B | Synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-111718250-B | Method for preparing R-citronellal | 万华化学集团股份有限公司 | 2022-04-22 | — | — | CN | claimed |
| CN-113640408-A | Method for analyzing piperidinol compound | 山东华素制药有限公司 | 2021-11-12 | — | — | CN | claimed |
| CN-113461598-A | Process for producing piperidinol compound | 山东华素制药有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-113264868-A | Improved synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2021-08-17 | — | — | CN | claimed |
| CN-113122050-A | Quantum dot ink and preparation method of quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-111848495-A | Synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2020-10-30 | — | — | CN | claimed |
| CN-111718250-A | Method for preparing R-citronellal | 万华化学集团股份有限公司 | 2020-09-29 | — | — | CN | claimed |
| EP-3115358-B1 | METHOD OF PREPARATION AND CHIRAL INVERSION OF CHIRAL-1-T-BUTOXYCARBONYL-3-HYDROXY PIPERIDINE | ABA CHEMICALS CORP (CN) | 2019-09-11 | — | — | EP | claimed |
| EP-3170809-B1 | METHOD FOR RECYCLING CHIRAL 1-BENZYL-3-HYDROXYPIPERIDINE BY RACEMIZATION | ABA CHEMICALS CORP (CN) | 2019-04-03 | — | — | EP | claimed |
| EP-3170809-A1 | METHOD FOR RECYCLING CHIRAL 1-BENZYL-3-HYDROXYPIPERIDINE BY RACEMIZATION | ABA Chemicals Corporation (CN) | 2017-05-24 | — | — | EP | claimed |
| EP-3115358-A1 | METHOD OF PREPARATION AND CHIRAL INVERSION OF CHIRAL-1-T-BUTOXYCARBONYL-3-HYDROXY PIPERIDINE | ABA Chemicals Corporation (CN) | 2017-01-11 | — | — | EP | claimed |
| CN-104140390-B | The racemization recovery method of a kind of chirality 1-benzyl-3-hydroxy piperidine | 雅本化学股份有限公司 | 2016-06-08 | — | — | CN | claimed |
| CN-103864673-B | The method of the preparation of chirality-1-tertbutyloxycarbonyl-3-hydroxy piperidine and chirality upset | ABA CHEMICALS CORPORATION (CN) | 2016-03-23 | — | — | CN | claimed |
| CN-104140390-A | Racemization recycling method for chirality 1-benzyl-3-hydroxypiperidine | ABA CHEMICALS CORP | 2014-11-12 | — | — | CN | claimed |
| CN-103864673-A | Preparation of chirality-1-t-butyloxycarboryl-3-hydroxy piperidine and method for chirality turning | ABA CHEMICALS CORP | 2014-06-18 | — | — | CN | claimed |
| US-12630528-B2 | Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | LG CHEM, LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12497530-B2 | Active energy ray polymerization initiator, active energy ray curing composition, active energy ray curing ink, aqueous active energy ray curing ink, container, image forming device, image forming method, and method of manufacturing active energy ray polymerization initiator | RICOH COMPANY, LTD. (JP) | 2025-12-16 | — | — | US | disclosed |
| CN-119977863-A | Synthesis process of (((2S) -4- (-) -3-hydroxy-4-oxo-1- ((S) -2- (-) -butan-2-yl) carbamic acid tert-butyl ester | 雅本化学股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-4071147-B1 | NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF | LG CHEMICAL LTD (KR) | 2025-03-26 | — | — | EP | disclosed |
| CN-114846013-B | Novel aminoaryl derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2024-12-20 | — | — | CN | disclosed |
| CN-117929563-A | Method for separating and measuring impurities and residual solvents in 1-benzyl-3-piperidinol | 重庆华邦制药有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-113461598-B | Process for producing piperidinol compound | 山东华素制药有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-113461598-B | Process for producing piperidinol compound | 山东华素制药有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-113265392-B | Cyano-group transfer catalyst and preparation method thereof | 山东华素制药有限公司 | 2023-03-24 | — | — | CN | disclosed |
| US-20230078941-A1 | NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF | LG CHEM, LTD. (KR) | 2023-03-16 | — | — | US | disclosed |
| CN-113640408-B | Method for analyzing piperidinol compound | 山东华素制药有限公司 | 2023-03-07 | — | — | CN | disclosed |
| US-20230032881-A1 | ACTIVE ENERGY RAY POLYMERIZATION INITIATOR, ACTIVE ENERGY RAY CURING COMPOSITION, ACTIVE ENERGY RAY CURING INK, AQUEOUS ACTIVE ENERGY RAY CURING INK, CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, AND METHOD OF MANUFACTURING ACTIVE ENERGY RAY POLYMERIZATION INITIATOR | RICOH COMPANY, LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| CN-113264868-B | Improved synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-113264868-B | Improved synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2022-12-02 | — | — | CN | disclosed |
| EP-3148518-B1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PRIVATE LTD (IN) | 2022-11-30 | — | — | EP | disclosed |
| CN-113122050-B | Quantum dot ink and preparation method of quantum dot film | TCL科技集团股份有限公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-4071147-A1 | NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF | Lg Chem, Ltd. (KR) | 2022-10-12 | — | — | EP | disclosed |
| CN-113426468-B | Wastewater treatment material and preparation method thereof | 山东华素制药有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114846013-A | Novel aminoaryl derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2022-08-02 | — | — | CN | disclosed |
| CN-111778297-B | Improved synthesis method of 1-benzyl-3-piperidinol intermediate | 山东华素制药有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-113307327-B | Wastewater treatment method for 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-111848495-B | Synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-111718250-B | Method for preparing R-citronellal | 万华化学集团股份有限公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-113640408-A | Method for analyzing piperidinol compound | 山东华素制药有限公司 | 2021-11-12 | — | — | CN | disclosed |
| CN-113461598-A | Process for producing piperidinol compound | 山东华素制药有限公司 | 2021-10-01 | — | — | CN | disclosed |
| CN-113461598-A | Process for producing piperidinol compound | 山东华素制药有限公司 | 2021-10-01 | — | — | CN | disclosed |
| CN-113426468-A | Wastewater treatment material and preparation method thereof | 山东华素制药有限公司 | 2021-09-24 | — | — | CN | disclosed |
| CN-113307327-A | Wastewater treatment method for 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2021-08-27 | — | — | CN | disclosed |
| CN-113264868-A | Improved synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-113264868-A | Improved synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-113265392-A | Cyano-group transfer catalyst and preparation method thereof | 山东华素制药有限公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-113122050-A | Quantum dot ink and preparation method of quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | disclosed |
| WO-2021133035-A1 | NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF | 주식회사 엘지화학 | 2021-07-01 | — | — | WO | disclosed |
| US-20210093618-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2021-04-01 | — | — | US | disclosed |
| CN-111848495-A | Synthesis method of 1-benzyl-3-piperidinol | 山东华素制药有限公司 | 2020-10-30 | — | — | CN | disclosed |
| CN-111778297-A | Improved synthesis method of 1-benzyl-3-piperidinol intermediate | 山东华素制药有限公司 | 2020-10-16 | — | — | CN | disclosed |
| CN-111718250-A | Method for preparing R-citronellal | 万华化学集团股份有限公司 | 2020-09-29 | — | — | CN | disclosed |
| US-20200108054-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2020-04-09 | — | — | US | disclosed |
| CN-105793238-B | Substituted benzamides and methods of use thereof | 基因泰克公司 | 2019-12-24 | — | — | CN | disclosed |
| EP-3115358-B1 | METHOD OF PREPARATION AND CHIRAL INVERSION OF CHIRAL-1-T-BUTOXYCARBONYL-3-HYDROXY PIPERIDINE | ABA CHEMICALS CORP (CN) | 2019-09-11 | — | — | EP | disclosed |
| EP-3170809-B1 | METHOD FOR RECYCLING CHIRAL 1-BENZYL-3-HYDROXYPIPERIDINE BY RACEMIZATION | ABA CHEMICALS CORP (CN) | 2019-04-03 | — | — | EP | disclosed |
| EP-3170809-B1 | METHOD FOR RECYCLING CHIRAL 1-BENZYL-3-HYDROXYPIPERIDINE BY RACEMIZATION | ABA CHEMICALS CORP (CN) | 2019-04-03 | — | — | EP | disclosed |
| US-10207993-B2 | Compounds as anti-tubercular agents | SPHAERA PHARMA PVT. LTD. (IN) | 2019-02-19 | — | — | US | disclosed |
| US-20170334851-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PVT. LTD. (IN) | 2017-11-23 | — | — | US | disclosed |
| US-20170334851-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PVT. LTD. (IN) | 2017-11-23 | — | — | US | disclosed |
| US-9694002-B2 | Substituted benzamides and methods of use thereof | GENENTECH, INC. (US) | 2017-07-04 | — | — | US | disclosed |
| US-20170183305-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PVT. LTD. (IN) | 2017-06-29 | — | — | US | disclosed |
| US-20170183305-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PVT. LTD. (IN) | 2017-06-29 | — | — | US | disclosed |
| EP-3170809-A1 | METHOD FOR RECYCLING CHIRAL 1-BENZYL-3-HYDROXYPIPERIDINE BY RACEMIZATION | ABA Chemicals Corporation (CN) | 2017-05-24 | — | — | EP | disclosed |
| US-20170087136-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2017-03-30 | — | — | US | disclosed |
| US-9546164-B2 | Substituted benzamides and methods of use thereof | GENENTECH, INC. (US) | 2017-01-17 | — | — | US | disclosed |
| EP-3115358-A1 | METHOD OF PREPARATION AND CHIRAL INVERSION OF CHIRAL-1-T-BUTOXYCARBONYL-3-HYDROXY PIPERIDINE | ABA Chemicals Corporation (CN) | 2017-01-11 | — | — | EP | disclosed |
| EP-3115358-A1 | METHOD OF PREPARATION AND CHIRAL INVERSION OF CHIRAL-1-T-BUTOXYCARBONYL-3-HYDROXY PIPERIDINE | ABA Chemicals Corporation (CN) | 2017-01-11 | — | — | EP | disclosed |
| EP-3074377-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | Genentech, Inc. (US) | 2016-10-05 | — | — | EP | disclosed |
| CN-104140390-B | The racemization recovery method of a kind of chirality 1-benzyl-3-hydroxy piperidine | 雅本化学股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| CN-103864673-B | The method of the preparation of chirality-1-tertbutyloxycarbonyl-3-hydroxy piperidine and chirality upset | ABA CHEMICALS CORPORATION (CN) | 2016-03-23 | — | — | CN | disclosed |
| CN-103864673-B | The method of the preparation of chirality-1-tertbutyloxycarbonyl-3-hydroxy piperidine and chirality upset | ABA CHEMICALS CORPORATION (CN) | 2016-03-23 | — | — | CN | disclosed |
| WO-2015131299-A1 | METHOD OF PREPARATION AND CHIRAL INVERSION OF CHIRAL-1-T-BUTOXYCARBONYL-3-HYDROXY PIPERIDINE | 雅本化学股份有限公司 | 2015-09-11 | — | — | WO | disclosed |
| US-20150252038-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | XENON PHARMACEUTICALS INC. (CA) | 2015-09-10 | — | — | US | disclosed |
| WO-2015078374-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2015-06-04 | — | — | WO | disclosed |
| CN-104140390-A | Racemization recycling method for chirality 1-benzyl-3-hydroxypiperidine | ABA CHEMICALS CORP | 2014-11-12 | — | — | CN | disclosed |
| CN-103864673-A | Preparation of chirality-1-t-butyloxycarboryl-3-hydroxy piperidine and method for chirality turning | ABA CHEMICALS CORP | 2014-06-18 | — | — | CN | disclosed |
| CN-103864673-A | Preparation of chirality-1-t-butyloxycarboryl-3-hydroxy piperidine and method for chirality turning | ABA CHEMICALS CORP | 2014-06-18 | — | — | CN | disclosed |
| US-8324222-B2 | Cyclically substituted furopyrimidine derivatives and use thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2012-12-04 | — | — | US | disclosed |
| WO-2012116945-A2 | LIQUID PHASE SEPARATION OF PLASMID DNA ISOFORMS AND TOPOISOMERS | BOEHRINGER INGELHEIM RCV GMBH & CO KG (AT) | 2012-09-07 | — | — | WO | disclosed |
| US-20120220729-A1 | LIQUID PHASE SEPARATION OF PLASMID DNA ISOFORMS AND TOPOISOMERS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-08-30 | — | — | US | disclosed |
| US-20110124665-A1 | Novel, Cyclically Substituted Furopyrimidine Derivatives and Use Thereof | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-05-26 | — | — | US | disclosed |
| EP-1966218-B1 | NOVEL, CYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES | BAYER SCHERING PHARMA AG (DE) | 2010-07-14 | — | — | EP | disclosed |
| US-20080274107-A1 | Tyrosine kinase inhibitors | MERCK SHARP & DOHME CORP. | 2008-11-06 | — | — | US | disclosed |
| US-20080274107-A1 | Tyrosine kinase inhibitors | MERCK SHARP & DOHME CORP. | 2008-11-06 | — | — | US | disclosed |
| WO-2008131859-A2 | USE OF CYCLICALLY SUBSTITUTED FUROPYRIMIDINE DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTONIA | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-11-06 | — | — | WO | disclosed |
| EP-1966218-A1 | NOVEL, CYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES | Bayer HealthCare AG (DE) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007079861-A1 | NOVEL, CYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES | BAYER HEALTHCARE AG (DE) | 2007-07-19 | — | — | WO | disclosed |
| US-7186723-B2 | Tyrosine kinase inhibitors | MERCK & CO., INC. (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186723-B2 | Tyrosine kinase inhibitors | MERCK & CO., INC. (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186723-B2 | Tyrosine kinase inhibitors | MERCK & CO., INC. (US) | 2007-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10207993-B2 | Compounds as anti-tubercular agents | FNTB, G6PD, PGGT1B | ALDH1A1 193/4885CYP2D6 865/4885CYP1A2 612/4885 |
| US-20210093618-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | BRIX1, RDX, SULT2A1 | ALDH1A1 912/4885CYP2D6 133/4885CYP1A2 79/4885 |
| US-20120220729-A1 | LIQUID PHASE SEPARATION OF PLASMID DNA ISOFORMS AND TOPOISOMERS | PCNA, RCC1, POLN | ALDH1A1 3661/4885CYP2D6 3972/4885CYP1A2 4614/4885 |
| US-20230078941-A1 | NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF | DGAT2, DGAT1, PLAAT2 | ALDH1A1 480/4885CYP2D6 390/4885CYP1A2 398/4885 |
| US-20110124665-A1 | Novel, Cyclically Substituted Furopyrimidine Derivatives and Use Thereof | DPYD, TK2, TPMT | ALDH1A1 472/4885CYP2D6 220/4885CYP1A2 360/4885 |
| US-20170334851-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | FNTB, PGGT1B, GGPS1 | ALDH1A1 467/4885CYP2D6 1722/4885CYP1A2 1475/4885 |
| US-12630528-B2 | Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | DGAT2, DGAT1, SOAT2 | ALDH1A1 597/4885CYP2D6 288/4885CYP1A2 368/4885 |
| US-20150252038-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | BRIX1, RDX, RRM1 | ALDH1A1 1306/4885CYP2D6 401/4885CYP1A2 178/4885 |
| US-20170087136-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | C1R, SRR, PNISR | ALDH1A1 1503/4885CYP2D6 220/4885CYP1A2 272/4885 |
| US-20200108054-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | BRIX1, RDX, SULT2A1 | ALDH1A1 912/4885CYP2D6 133/4885CYP1A2 79/4885 |
| US-20080274107-A1 | Tyrosine kinase inhibitors | ERBB2, TYRO3, TIE1 | ALDH1A1 3104/4885CYP2D6 4826/4885CYP1A2 4812/4885 |
| US-20170183305-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | FNTB, PGGT1B, GGPS1 | ALDH1A1 467/4885CYP2D6 1722/4885CYP1A2 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.